M&A Deal Summary

SRA International Acquires Constella Group

On August 9, 2007, SRA International acquired healthcare services company Constella Group from Pamlico Capital

Acquisition Highlights
  • This is SRA International’s 1st transaction in the Healthcare Services sector.
  • This is SRA International’s 2nd transaction in the United States.
  • This is SRA International’s 1st transaction in North Carolina.

M&A Deal Summary

Date 2007-08-09
Target Constella Group
Sector Healthcare Services
Buyer(s) SRA International
Sellers(s) Pamlico Capital
Deal Type Add-on Acquisition
Advisor(s) William Blair (Financial)

Target

Constella Group

Durham, North Carolina, United States
Constella Group, Inc. is a professional health services company, dedicated to enhancing human health through innovative science, technology and knowledge solutions. Constella's three business units-Health Sciences, Clinical Informatics and Futures Group-create and provide health intelligence to help industry and government clients identify and solve critical problems affecting human health.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

SRA International

Fairfax, Virginia, United States

Category Company
Founded 1976
Sector Information Technology
Employees5,200
DESCRIPTION

SRA International is a provider of technology and strategic consulting solutions to government organizations. SRA International was formed in 1976 and is based in Fairfax, Virginia.


DEAL STATS #
Overall 2 of 5
Sector (Healthcare Services) 1 of 1
Type (Add-on Acquisition) 2 of 4
State (North Carolina) 1 of 1
Country (United States) 2 of 5
Year (2007) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2006-10-04 RABA Technologies

Columbia, Maryland, United States

RABA is a leader in providing top tier information technology services for government and commercial applications.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2010-01-31 Perrin Quarles Associates

Charlottesville, Virginia, United States

Perrin Quarles Associates, Inc. is an environmental consulting firm that specializes in environmental program development and implementation for air quality and climate change.

Buy -

Seller(S) 1

SELLER

Pamlico Capital

Charlotte, North Carolina, United States

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1988
PE ASSETS 3.5B USD
Size Large
Type Sector Agnostic
DESCRIPTION

Pamlico Capital is a private equity group focused on mid-sized transactions. Pamlico looks to invest $25 to $125 million per transaction. Sectors of interest include business and technology services, consumer products/services, industrial, energy, financial services, healthcare, media, and communications. Pamlico will consider both minority and majority positions. Prospective transactions include management or leveraged buyouts, recapitalizations, growth financings, mezzanine, and special situations. Pamlico was formerly known as Wachovia Capital Partners. The Firm was originally formed in 1988 and is based in Charlotte, North Carolina.


DEAL STATS #
Overall 12 of 61
Sector (Healthcare Services) 2 of 6
Type (Add-on Acquisition) 5 of 32
State (North Carolina) 2 of 4
Country (United States) 12 of 59
Year (2007) 5 of 6
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2007-07-01 American Community Newspapers

Leesburg, Virginia, United States

American Community Newspapers LLC is a publisher of community newspapers, daily newspapers, a weekly shopper and business and specialty publications.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2007-09-25 Biomet

Warsaw, Indiana, United States

Biomet, Inc. is a designs and manufactures orthopedic medical devices and other products used primarily by surgeons and medical specialists, with distribution in over 70 countries and a product portfolio that encompasses orthopedic joint replacement products, dental reconstructive implants, fixation devices, spinal products and other applications.

Buy $11.4B